Status:
RECRUITING
Implementation of CBT-I in Cancer Clinics
Lead Sponsor:
CHU de Quebec-Universite Laval
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Canadian Cancer Society (CCS)
Conditions:
Insomnia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Insomnia affects 30-60% of cancer patients, thus making it one of the most common disturbances in this population. When untreated, which is the rule rather than the exception, insomnia often becomes c...
Eligibility Criteria
Inclusion
- have received a diagnosis of non-metastatic cancer (any type)
- to be aged 18 years and older
- to be readily able to read and understand French or English
- having the minimum cognitive abilities to read, understand and memorize information
- having access to Internet
Exclusion
- having a psychological comorbidity needing clinical attention (e.g., major depressive disorder)
- having severe cognitive impairments (e.g., diagnosis of Parkinson's disease, dementia)
- having insomnia due to a temporary condition (e.g., acute pain, short-term medication side effects, environmental factors)
Key Trial Info
Start Date :
December 13 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04817163
Start Date
December 13 2019
End Date
May 30 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de recherche de L'Hôtel-Dieu de Québec
Québec, Canada, G1R 2J6